Sir Harpal is the President of GRAIL Europe.
He most recently served as Senior Vice President and Head of Innovation EMEA at Johnson & Johnson.
Before joining J&J, Sir Harpal spent 15 years with Cancer Research UK (CRUK) and served as the organisation’s Chief Executive Officer from April 2007 until June 2018.
Prior to this, he was Chief Operating Officer & Executive Director of Development at CRUK and served as Chief Executive of Cancer Research Technology (a subsidiary of CRUK).
Before CRUK, he worked with McKinsey & Co, and was CEO of The Papworth Trust
and Nexan Group.
Sir Harpal received a first-class Masters in Chemical Engineering from the University of Cambridge, and an MBA as a Baker Scholar from Harvard Business School.
He has been awarded Honorary Doctorates from the universities of Manchester, Newcastle, and Glasgow, and the Institute of Cancer Research.
He is an Honorary Fellow of the Academy of Medical Sciences, Royal College of
Radiologists, Association of Cancer Physicians (UK) and St John’s College,
University of Cambridge.
In 2016, he was knighted by Her Majesty Queen Elizabeth II for services to cancer research. He is a Board Member of UK Research & Innovation and Our Future Health and is a member of the UK government Innovation Expert Group and the Oversight Committee of the COVID-19 National Core Studies.
Last updated: 15 February 2021